NLS In a new job

In a new job - January 10, 2017

New CFO of Targovax

Targovax ASA announces that Erik Digman Wiklund has been appointed as the Company’s new Chief Financial Officer, and will take up this role in April 2017. The previous CFO, Oystein Soug, was appointed as Targovax’s CEO on 2 November 2016. Erik joins from the nutraceutical company Aker Biomarine Antarctic AS, where he held the position […]

In a new job - January 10, 2017

Maria Carell joins the board of Pharmalink

Pharmalink AB, announces the election of Maria Carell as Chair of the company’s Board of Directors. Carell replaces Hilde Furberg as Chair, who is elected Vice Chair of the company’s Board of Directors. She has an extensive background in operating, acquiring and developing healthcare and life science companies. She has previously held the position as CEO […]

In a new job - January 5, 2017

Björn Westberg to join BONESUPPORT as CFO

BONESUPPORT announces that Björn Westberg is to join the company as Chief Financial Officer and Director in early 2017. Mr Westberg brings nearly 30 years’ finance and management experience to BONESUPPORT. He joins from Recipharm  where he has been CFO since 2007. Prior to this he was CFO of the listed (Nasdaq Stockholm) software company Jeeves […]

In a new job - January 5, 2017

Marc Gailhardou new CEO of MSD Sweden

Marc Gailhardou is the new CEO of MSD Sweden and starting from this year he will be situated at MSD’s Swedish office in Hagastaden Stockholm. Previously he has been a part of the European corporate group at Sanofi Pasteur MSD, responsible for ten countries. “I am proud to continue to develop and grow SPMSD’s 20 […]

In a new job - December 1, 2016

New chief adviser for AZ’s genomics initiative

Professor David Goldstein will join AstraZeneca’s in the consultative role of Chief Adviser, Genomics to lead its integrated genomics initiative, which was announced in April. This 10-year initiative will focus on the discovery of new targets and biomarkers linked to molecular mechanisms of disease across AstraZeneca’s main therapy areas. Professor Goldstein will continue in his full-time […]

In a new job - November 21, 2016

Acesion Pharma recruits new CFO

Acesion Pharma, a Danish biotech company developing novel treatments for atrial fibrillation (AF), announced that it has recruited Jakob Dynnes Hansen as its Chief Financial Officer to succeed Herik Moltke, who will continue as CFO of Scandinavian Micro Biodevices that was recently acquired by Zoetis. Jakob joins Acesion from Evolva, a Swiss biotech company, where […]

We Value Your Privacy

This site uses cookies

We use cookies to improve your experience on our site. By clicking "accept," you agree to our use of cookies.

Read more about our privacy policy

Only necessary
Accept All
Manage Cookies

Manage Cookies

functional

The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.

market

The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.

personal

The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.